MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Severe hypomimia in drug naïve Parkinson´s disease patients may predict mild cognitive impairment

    C. Gasca-Salas, L. Vela, J. Obeso (Alcorcón, Spain)

    Objective: We aimed to analyze if hypomimia was associated with mild cognitive impairment in Parkinson´s disease  (PD-MCI) and if it predicted cognitive decline. Background: Hypomimia…
  • 2019 International Congress

    Identifying delirium in people with Parkinson’s disease: the Determine-PD pilot study

    R. Lawson, S. Richardson, A. Yarnall, D. Burn, L. Allan (Newcastle Upon Tyne, United Kingdom)

    Objective: To identify the prevalence of delirium in inpatients with Parkinson’s disease (PD). Background: People with PD may be at increased risk of delirium and…
  • 2019 International Congress

    Quantitative EEG measures reflect general cognitive status in Parkinson’s disease

    C. Navarro-Roa, M. Rodriguez-Violante, G. Sanchez-Dinorin, A. Cervantes-Arriaga, R. Solis-Vivanco (Mexico City, Mexico)

    Objective: To explore the utility of the quantitative electroencephalogram (EEG) as a potential biomarker of cognitive status in patients with Parkinson's disease (PD). Background: While…
  • 2019 International Congress

    Movement disorders spectrum in patients with frontotemporal dementia

    YU. Shpilyukova, E. Fedotova, D. Grishina, S. Illarioshkin (Moscow, Russian Federation)

    Objective: To determine frequency of different hypokinetic and hyperkinetic movement disorders (MD) within a spectrum of frontotemporal dementia (FTD): we examined patients with behavioral and…
  • 2019 International Congress

    Visual hallucinations in Lewy Body Disease are characterised by impaired sensory integration

    A. Zarkali, R. Adams, L. Leyland, G. Rees, R. Weil (London, United Kingdom)

    Objective: To test whether increased reliance on prior knowledge is associated with visual hallucinations in Lewy Body Disease (LBD: Parkinson’s disease and Dementia with Lewy…
  • 2019 International Congress

    Lymphocyte Senescence in Parkinson’s Disease

    M. Jensen, K. Scott, M. Camacho, A. Kouli, R. Wijeyekoon, I. Solim, R. Barker, C. Williams-Gray (Cambridge, United Kingdom)

    Objective: To characterise T- and B-lymphocyte senescence in early stage Parkinson’s disease (PD). Background: Evidence suggests that the immune system may contribute to PD aetiopathogenesis,…
  • 2019 International Congress

    Spiral Analysis Evaluates the Effects of Deep Brain Stimulation in Parkinson disease and Essential Tremor

    S. Radmard, S. Pullman (New York, NY, USA)

    Objective: To apply computerized spiral analysis to investigate upper limb kinematics and impact of deep brain stimulation (DBS) on motor dysfunction in Parkinson disease (PD) and…
  • 2019 International Congress

    Movement disorders in neurologic consultation of Marrakesh University Hospital

    L. Berrhoute, J. El Mesbahy, N. Kissani (Marrakesh, Morocco)

    Objective: Describing the epidemiological and clinical aspects of the movement’s disorders in Marrakesh. Analyzing difficulties of management of this disease. Comparing our data with international…
  • 2019 International Congress

    Association between Parkinson disease and the risk of cardiovascular disease and all-cause mortality: A nationwide, register-based cohort study

    DH. Kim, DY. Kwon, MH. Park, KW. Park (Ansan City, Republic of Korea)

    Objective: This nationwide population-based, matched cohort study aimed to determine whether patients with PD have an increased risk of MI, stroke, and mortality by using…
  • 2019 International Congress

    Number of people with Parkinson’s dementia in New Zealand

    T. Pitcher, D. Myall, J. Dalrymple-Alford, M. Macaskill, T. Anderson (Christchurch, New Zealand)

    Objective: To estimate the number of people with Parkinson’s disease dementia (PDD) in New Zealand and how this has changed over time. Background: People with…
  • « Previous Page
  • 1
  • …
  • 126
  • 127
  • 128
  • 129
  • 130
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley